SCHEMBL30865902

SCHEMBL30865902

CCN(CC)CCCN(C(=O)c1ccc(C(N)=O)cc1Cl)c1ccc(Cl)c(-c2ccccn2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.39
ALB P02768 1/20 0.38
HTR1A P08908 1/20 0.38
SLC6A2 P23975 1/20 0.38
PDE4A P27815 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
HTR2B P41595 1/20 0.38
SLC6A3 Q01959 1/20 0.38
PDE4D Q08499 1/20 0.38
SHH Q15465 1/20 0.38
USP28 Q96RU2 1/20 0.38
SLC29A1 Q99808 1/20 0.38
SMO Q99835 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
CYP3A4 P08684 2/20 0.37
NTRK1 P04629 2/20 0.36
PDK1 Q15118 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1593585 1.00 RORC (0.39) RORCALBHTR1ASLC6A2PDE4A
SCHEMBL2570621 0.93 ALB (0.38) RORCALBHTR1ASLC6A2PDE4A
SCHEMBL30865909 0.90 RORC (0.47) RORCALBHTR1ASLC6A2PDE4A
SCHEMBL30865874 0.89 NTRK1 (0.38) RORCALBHTR1ASLC6A2PDE4A
SCHEMBL30865890 0.88 ALB (0.39) RORCALBHTR1ASLC6A2PDE4A
SCHEMBL17783737 0.88 ALB (0.39) RORCALBHTR1ASLC6A2PDE4A
SCHEMBL30865911 0.88 ALB (0.40) RORCALBHTR1ASLC6A2PDE4A
SCHEMBL17783748 0.86 ALB (0.41) ALBHTR1ASLC6A2PDE4AOPRM1
SCHEMBL30865904 0.85 ALB (0.44) RORCALBHTR1ASLC6A2PDE4A
SCHEMBL30865879 0.84 NAMPT (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116872-A1 PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2024-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116872-A1 PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING SHH, GLI1, SMO RORC 1119/4885ALB 4881/4885HTR1A 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.